Elsevier Starts Its Collaboration with the National Natural Science Foundation of China

Optimizing governance and management of science and technology funding in China through access to Scopus and SciVal

Beijing, October 17, 2013

Elsevier, a world-leading provider of scientific, technical and medical information products and services today announced its official collaboration with the National Natural Science Foundation of China (NSFC), the central governing body for science and technology funding in China.

With an official memorandum of understanding (MoU) in place, Elsevier will undertake to provide services to NSFC to help the organization optimize the utilization and disbursement of research funds for projects. This includes:

"NSFC is exploring a more objective data and analytical tools to analyse, investigate and improve the process of fund management," said Ruiping Gao, NSFC Vice President.

Elsevier's Managing Director of Academic and Government Institutional Markets, Nick Fowler said, "Elsevier is pleased to support NSFC in analysing and evaluating where and how research funds should be allocated using Scopus data, SciVal's research intelligence tools, and Elsevier's expertise."


# # #


About National Natural Science Foundation of China

The National Natural Science Foundation of China (NSFC) is an organization directly affiliated to the State Council for the management of the National Natural Science Fund. Founded in February 1986 with the approval of the State Council, NSFC is an institution that oversees the management of the National Natural Science Fund for the promotion and financing of both basic and applied research in China (http://www.nsfc.gov.cn/Portal0/default166.htm).

About Scopus
Scopus, the largest abstract and citation database of peer-reviewed literature, features smart tools to track, analyze and visualize scholarly research. Its vast database contains abstracts and references from 21,000 titles from more than 5,000 publishers worldwide, ensuring broad interdisciplinary coverage in the fields of science, technology, medicine, social sciences and Arts & Humanities. Scopus was designed and developed with input from researchers and librarians internationally; and features direct links to subscribed full-text articles, other library resources and interoperability with applications such as reference management software.

About Elsevier's SciVal
Built on Elsevier's 130-year heritage in the world of research, SciVal helps institutions make more informed decisions to drive research outcomes. Serving research institutions, funders and policy makers, our objective data and trusted solutions enable organizations to build their portfolios, optimize funding flows, assemble collaborative partnerships and manage research activities. Elsevier integrates institutional and external data sources with information from Scopus, the world's largest abstract and citation database, to provide innovative solutions including Pure, SciVal Experts, SciVal Funding, SciVal Spotlight, SciVal Strata and SciVal Analytics.

About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group PLC is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Jason Chan
Director, Corporate Relations, Asia Pacific
Elsevier
+65 6349 0240
j.chan@elsevier.com


Cherry Li
Senior Customer Develop Manager, China & HK
Elsevier
+86 10 8520 8787
c.li@elsevier.com